YR, L., YL, X., Y, X., C, D., & Q, W. (2025). Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes. Clinical pharmacokinetics, 64(4), 533. https://doi.org/10.1007/s40262-025-01475-7
Chicago Style (17th ed.) CitationYR, Lou, Xu YL, Xiong Y, Deng C, and Wang Q. "Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes." Clinical Pharmacokinetics 64, no. 4 (2025): 533. https://doi.org/10.1007/s40262-025-01475-7.
MLA (9th ed.) CitationYR, Lou, et al. "Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes." Clinical Pharmacokinetics, vol. 64, no. 4, 2025, p. 533, https://doi.org/10.1007/s40262-025-01475-7.